Verrica Pharmaceuticals Inc’s filing revealed that its CMO Rosenberg Noah L. acquired Company’s shares for reported $10000.0 on Nov 25 ’25. In the deal valued at $4.24 per share,2,357 shares were bought. As a result of this transaction, Rosenberg Noah L. now holds 2,357 shares worth roughly $17795.35.
Then, Kirby John J. bought 3,536 shares, generating $15,001 in total proceeds. Upon buying the shares at $4.24, the Interim CFO now owns 8,962 shares.
Before that, Zawitz David bought 10,000 shares. Verrica Pharmaceuticals Inc shares valued at $42,425 were divested by the Chief Operating Officer at a price of $4.24 per share. As a result of the transaction, Zawitz David now holds 21,000 shares, worth roughly $0.16 million.
H.C. Wainwright downgraded its Verrica Pharmaceuticals Inc [VRCA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Sector perform”. Needham also remained covering VRCA and has increased its forecast on July 25, 2023 with a “Buy” recommendation from previously “Hold” rating. Jefferies started covering the stock on March 22, 2023. It rated VRCA as “a Buy”.
Price Performance Review of VRCA
On Monday, Verrica Pharmaceuticals Inc [NASDAQ:VRCA] saw its stock fall -17.03% to $7.55. Over the last five days, the stock has gained 79.33%. Verrica Pharmaceuticals Inc shares have fallen nearly -31.98% since the year began. Nevertheless, the stocks have risen 7.86% over the past one year. While a 52-week high of $13.20 was reached on 11/28/25, a 52-week low of $3.28 was recorded on 11/04/25.
Levels Of Support And Resistance For VRCA Stock
The 24-hour chart illustrates a support level at 7.17, which if violated will result in even more drops to 6.79. On the upside, there is a resistance level at 8.06. A further resistance level may holdings at 8.56.
How much short interest is there in Verrica Pharmaceuticals Inc?
A steep rise in short interest was recorded in Verrica Pharmaceuticals Inc stocks on 2025-11-14, growing by 0.14 million shares to a total of 0.45 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 0.3 million shares. There was a rise of 32.35%, which implies that there is a positive sentiment for the stock.
